Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial. [electronic resource]
Producer: 20091008Description: 1705-14 p. digitalISSN:- 0315-162X
- Administration, Oral
- Adult
- Aged
- Alendronate -- administration & dosage
- Biomarkers -- metabolism
- Bone Density -- drug effects
- Bone Density Conservation Agents -- administration & dosage
- Calcium -- administration & dosage
- Drug Therapy, Combination
- Female
- Glucocorticoids -- adverse effects
- Hip Joint -- drug effects
- Humans
- Lumbar Vertebrae -- drug effects
- Male
- Middle Aged
- Osteoporosis -- chemically induced
- Placebos
- Rheumatic Diseases -- drug therapy
- Vitamin D -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.